Literature DB >> 2777250

Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemia.

J Inazawa1, H Nishigaki, H Takahira, J Nishimura, S Horiike, M Taniwaki, S Misawa, T Abe.   

Abstract

Rearrangement of the breakpoint cluster region (bcr) and the chromosomal location of c-abl and 3'-bcr were studied in two patients with Philadelphia chromosome (Ph1)-negative chronic myelocytic leukemia (CML). One patient (patient 1) had a normal karyotype and the other (patient 2), 46,XY,inv(3)(q21q26). Both patients showed the bcr rearrangement by Southern blot analysis with a 1.2kb 3'-bcr probe. In situ hybridization studies demonstrated the location of the homologous sequences of bcr on chromosome 22 in patient 1, and on chromosomes 9 and 22 in patient 2. These findings indicate that the morphologically normal-looking chromosomes 9 and 22 in patient 2 are the result of a retranslocation between chromosomes 9q+ and 22q-, abnormalities which were first formed by a standard Ph1 translocation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777250     DOI: 10.1007/BF00286701

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  The Philadelphia chromosome. Considerations based on studies of variant Ph translocations.

Authors:  T Ishihara; M Minamihisamatsu
Journal:  Cancer Genet Cytogenet       Date:  1988-05

2.  Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization.

Authors:  M E Harper; G F Saunders
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

3.  Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia.

Authors:  C M Morris; A E Reeve; P H Fitzgerald; P E Hollings; M E Beard; D C Heaton
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

4.  Do oncogenes determine clinical features in chronic myeloid leukaemia?

Authors:  O Dreazen; I Klisak; F Rassool; J M Goldman; R S Sparkes; R P Gale
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

5.  Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.

Authors:  J B Konopka; S M Watanabe; J W Singer; S J Collins; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

Authors:  Y Ben-Neriah; G Q Daley; A M Mes-Masson; O N Witte; D Baltimore
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

7.  Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia.

Authors:  T S Ganesan; F Rassool; A P Guo; K H Th'ng; C Dowding; J A Hibbin; B D Young; H White; T O Kumaran; D A Galton
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

  7 in total
  2 in total

1.  A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript.

Authors:  T Wakayama; Y Maniwa; H Ago; N Kakazu; T Abe
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

2.  Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene.

Authors:  Fumihiko Monma; Kazuhiro Nishii; Shunji Yamamori; Noboru Hosokai; Takahiro Nakazaki; Felipe Lorenzo; Eiji Usui; Miho Sakakura; Hiroyuki Miyashita; Atsushi Fujieda; Kohshi Ohishi; Naoyuki Katayama; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.